Zanubrutinib plus R-CHOP for the treatment of newly diagnosed double-expressor lymphoma: A phase 2 clinical study.
Yin X, He Q, Liu D, Xie L, Wang H, Chen C, Zhao C, Shan N, Shi S, Wei H, Ma J, Lu K, Wang L, Wang Y, Xing L, Li Z.
Yin X, et al. Among authors: xing l.
Cancer. 2025 Jan 1;131(1):e35697. doi: 10.1002/cncr.35697.
Cancer. 2025.
PMID: 39748728
Free PMC article.
Clinical Trial.